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Conclusions: These data show that a successful surveillance 
system that provides reliable reference data has been established in 
Germany. A number of quality management activities have been 
started in the participating hospitals, and many more hospitals would 
like to join the project in 1999 
1 1  Diphtheria in Europe 
A. Ektratiou, K.H. Engler, J. Douboyas, C. von Hunolstein, 
J. Vuopio-Varkila, 0. Patey, FA.D. Grimont. PHLS-Re$piratury and 
Systemic Infection Laboratory, Londurz, UK 
Objectives: Within the remit of the European Commission DGXII, 
BioMed 2 programme (1998-2001), to form a network of 
Diphtheria Reference Centres within Europe, so as to improve 
communication and exchange of information between countries on 
the epidemiology and microbiology of infections caused by 
Corynebacterium diphtheriae and C. ulcerans 
Methods: This has been achieved by the award of a DGXII grant 
from the European Commission, the effective collaboration of coun- 
tries within and external to Europe, along with the standardization 
of methodologies and protocols for microbiological surveillance of 
diphtheria. An international quality assurance scheme for laboratory 
performance in diagnostic and typing methodologies has been 
established in order to monitor these activities 
Results: The formation of Diphtheria Reference Centres within 
member states provides the basis for rapid exchange of information 
between countries and the availability of facilities for the micro- 
biological diagnosis of diphtheria. Established centers exist in the UK 
and Finland, with new centers currently being established in France, 
Greece and Italy Epidemiologic and molecular typing databases have 
also been developed for the identification and verification of new and 
existing strains that have the potential to cause epidemics; this is 
crucial for the monitoring and elimination of this resurgent disease 
from the European region 
Conclusions: As diphtheria declines within Europe, accurate, 
sensitive and specific laboratory confirmation of suspect cases 
becomes even more important and highlights the need for countries 
to maintain and increase both clinical and laboratory awareness. 
ESBL-Ea outbreak characterization 
C. Ardanuy, M. Pujol, M.A. Dominguez, E Tubau, J. Ariza, 
J. Lifiares. Hospital de Belluifge, Microbiolugy, Barcelona, Spain 
During a 6-week period (September to November 1997), 18 extended- 
spectrum /?-lactamase-producing Enterobacter aerogenes (ESBL-Ea) 
strains were isolated in clinical samples from five ICU patients. Three 
patients developed bacteremia, one a surgical wound infection and 
one colonization of the respiratory tract. The prior ICU average 
patient stay was 27.8 days, with all patients receiving prior cephalo- 
sporin therapy. The emergence of ESBL-Ea was coincidental with a 
substantial increase in the use of fourth-generation cephalosporins 
(4GC) in previous months. All the isolates were resistant to 
ceftazidime, cefotaxime, aztreonam, tobramycin, ciprofloxacin, tetra- 
cycline and co-trimoxazole, and susceptible to imipenem, gentamicin 
and amikacin by the microdilution method. ESBL production was 
detected by double disk diffusion test, but the ESBL Etest failed to 
detect it. Two b-lactamases of PI 6.5 and PI 8.5 were detected by 
isoelectric focusing analysis of enzymatic extracts. The PI 6.5 b- 
lactamase could be transferred by conjugation, conferring an ESBL 
resistance phenotype to transconjugants. The PI 8.2 b-lactamase 
could not be transferred; therefore, it was considered to be chmmo- 
somal. The ESBL was included in the TEM family by PCR. Geno- 
typic characterization showed a single clone by pulsed-field gel 
electrophoresis, and an identical plasmid profile in all the isolates. 
After introduction of isolation measures and 4GC restriction, no new 
cases of infection or colonization by the epidemic strain were 
detected. The conclusion is that the clustered infections due to 
iiiultiresistant Ea observed were caused by the spreading of an 
epidemic clone TEM-type ESBL producer, and disappeared after 
implementation of isolation measures and reduction of 4GC 
consumption. 
Fungal diseases: diagnosis, virulence factors, 
antifungal agents 
vl Comparative evaluation of PCR and serology 
for diagnosis of aspergillosis in patients with 
hematologic malignancies 
J. Roth', E. Engelmannz, M. Mielke*, D. Huhn', M. Ruhnke'. 
'Department of Hematology and Oncology, Charite', HU-Berlin, 
Zlnstiute o f  Microbiology, Freie Uniuersith't Berlin, Germany 
Objectives: In this study we compared the diagnostic value of two 
different methods that both promise to provide early and sensitive 
detection of invasive aspergillosis (IA) 
Methods: We used a PCR-based method which amplifies a 
fungus-specific 18s rRNA fragment with subsequent species-specific 
hybridization (according to Einsele et al; DNA extraction had been 
modified) as well as the Platelia Aspergillus antigen detection system 
(Sanofi Pasteur). Within a period of 18 months, blood and BAL (if 
available) of 34 patients with hematologic malignancies (NHL, n=7; 
AML, n=18; ALL, n = 3 ;  CML, n=6) were prospectively sampled 
once or twice a week during hospital stay and processed as described 
above (samples: n=226 ). Sixteen patients showed no clinical or 
laboratory evidence for IA (group A), and 12 patients had clinical and 
radiologic signs of probable IA (group B). Group C was composed 
ofsix patients with proven IA (five histologically proven, one positive 
in repeated BAL) 
Conclusion: The Platelia test appeared to provide more 
conclusive results in proven IA than the PCR-based method. 
Diagnosis in invasive pulmonary aspergillosis, 
an animal model 
M. Becker, S. de Marie, D. Willemse, I.A.J.M. Bakker- 
Woudenberg, Erasmus Med. Center Rotterdam, Med. Microbiology 6 
l n j  Diseases, Rotterdam, The  Netherlands 
Objective: Two diagnostic tests, ELISA for circulating galacto- 
mannan and PCR, were compared for diagnosing and monitoring 
invasive pulmonary aspergillosis in an animal model 
Methods: In a model of invasive left-sided pulmonary aspergillosis 
in persistently neutropenic rats, dissection was performed on day 1, 
day 3, day 5 and day 7 (n=20 each day) after inoculation. Within 
blood samples, PCR as well as ELISA was performed. Fungal 
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disseniination to other organs (right lung, liver, kidney, brain) was 
determined. In addition, 20 rats were serially sampled, 10 for each 
test 
Results: PCR was positive in 0% of the rats on day 1, 20% on 
day 3 ,  25% on day 5 and 40%) on day 7. ELISA was positive in 0% 
on day I ,  100% on day 3, 90% on day 5 and 95'% on day 7. The 
combinations positive ELISA-negative PCR as well as negative 
ELISA-positive P C R  were observed. Positive ELISA or PCR was 
not associated with fungal dissemination. Serial testing showed 
consistently increasing concentrations of galactomannan during the 
course of disease. In contrast, positive PCR could be followed by 
negative results 
Conclusions: ELISA was more sensitive than PCR, especially in 
the early phase of the disease. Concentrations of galactomannan 
increased significantly with the increase of severity of disease, in 
contrast to PCR. 
In vitro activity of antifungal agents against 
clinical Scedosporium isolates 
J. Meletiadis', J. Meis', A. Rijs', J. Mouton', J. Rodriguez-Tudela', 
F? Verweij' . 'Department of Medical hficrobiology, Clnitwsity Hospital 
Njmepi ,  'Departmcnt qf Afedical Microbiology, C WZ Hospital, 
Nijniegen, The Netherlands; -'National Centerfur Microbiology, Institutu 
dc Salird Carlos 111, Madrid, Spain 
Objectives: To determine the in vitro activity of amphotericin B 
(AB), miconazole (MCZ), itraconazole (ITZ), voriconazole (VCZ), 
UR9825 (UR), terbinafine (TB) and combinations of antifungal 
azolez and TB against 35 clinical isolates of Siedosporium prolificans (23 
isolates) and Scedosporiirm apiospermum (12 isolates) 
Methods: The MIC was determined by a broth microdilution 
method according to the proposed standardized testing of filamentous 
fungi by the NCCLS. Each drug was serially two-fold diluted to 
obtain concentrations ranging from 64 to 0.06 mg/L. Candida 
parapsilosis, C. krusei and Paecilontyces variorii were included as control 
isolates. The plates were incubated at 37OC and read after 48 and 72 h 
ofincubation. The MIC was determined at the lowest concentration 
showing 75% visible growth inhibition compared with the growth 
control. Only for AF3 was the MIC determined at the lowest concen- 
tration showing 100% inhibition of visible growth 
Results: The MICWS for S. apiospermum of MCZ, ITZ, UR, 
VCZ, T B  and Au were 1 mg/L (range 0.125-I), 2 mg/L (0.03-2), 
1 nig/L (0.03-l), 0.25 mg/L (0.03-0.5), 32 mg/L (2-32) and 4 mg/L 
(0.5-8), respectively, and for S. prol!fcans they were16 mg/L (2-16), 
32 mg/L (2-33, 2 mg/L (0.5-4), 4 mg/L (1-4). 16 mg/L (1-32) 
and 16 mg/L (I-16), respectively. For selected isolates of S. prol$cam, 
synergy was observed between antifungal azoles and TB 
Conclusions: VCZ and UR appeared to be the most active drugs 
against S. aptosperinnm and S. prolificans in vitro, and possible synergy 
between antifungal azoles and TB requires further study. 
FI Molecular typing of Candida afbicans, Candida 
tropicalis and Candida parapsilosis clinical 
isolates 
G. Vrioni'.', E. Papoutsaki', P. Matsiota-Bernard', 'Microbiology 
Ldboratory, K4T Hospital, Athens, Greece; 'hboratoire de Alicrohiolo~ic, 
Hopital Raymond Poicare, Paris, France 
Objectives: The object of our research was the molecular 
epidemiology of Candida isolates from patients in the intensive care 
unit (ICU) of a large tertiary-care hospital within a short period of 
time 
Methods: isolates were recovered from blood, deep trauma, 
urine, sputum and the environment. The isolates were identified 
using the API ID 32C (bioMerieux) and the Vitek YBC automated 
system (bioMericux) as C. ulbicans (22 strains), C. tropicalis (16 strain?) 
and C. parapsilosis (10 strains). The epidemiologic relation of the 
isolates was tested with random amplified polymorphic DNA 
(RAPD) analysis using four arbitrarily chosen primers. The resultt 
from KAPD analysis were confirmed with the pulsed-field electro- 
phoresis assay 
Results: We found that all C. albicaiu isolates presented distinct 
RAPD profiles, all C. parapsilosis isolates presented the mile RAPD 
pattern, and the C. tropicalis strains presented the same and distinct 
patterns 
Conclusions: We concluded that the C. albicarrr infection (or 
colonization) was endogenous, the C. parapsiloris infection has an 
environmental origin, and the C. tropicalis infection can be both 
endogenous and environmental 
Secreted lipases in Candida albicans: cloning 
and characterization of a new group of 
putative virulence genes 
B. Hube', M. Bossenz', A. Mazur', M. Ghannouiii2, W. Schafer'. 
'Institute f o r  GeJled Botany, University qf Hamliuy,  Gcrmariy; 'Cerirer 
f o r  Medical hiycoloyy, Deriiiadogy, Cleveland, O H ,  LrS4 
Secreted hydrolytic enzymes such as protcinases m d  phospholipases 
are known as prorninent virulence factors of the human opportunistic 
pathogen Caridida alliicans. We were able to show that, in addition to 
the secretion of proteinases and phospholipases, C. alliicaru also 
displays a number of lipolytic activities under a range of enviroii- 
inental conditions. The fungus was able to grow on media with lipids 
such as Tween or olive oil as sole source of carbon, but also secreted 
lipases during the yeast to hyphal transition and in media containing 
glucose, Secreted lipases are active at pH ranges from 3.0 to 6.0. 
These lipolytic activities are due to a large number of lipate genes 
which we called the LIP gene family 
The C. albicans lipase gene LIPl has recently been cloned and 
sequenced. Using LIPl  as a hybridization probe, we cloned and 
sequenced LIP2, LIP3 and LIP4. Southern anaiysis and sequence 
aligninents suggest that at least six more LIP genes exist in C. <ilbicam. 
All sequenced LIP genes contain open reading frames of 1380-141 6 
by encoding a deduced protein of 50 kDa with putative tignal 
peptides. LIPl-LIP.1 have no homologies to any lipase genes of S. 
cerevisae, including the triglycerol lipase genes TGLl and TGL?, and 
thup have no counterpart in this closely related apathogenic yeast. In 
contrast, the highest homology was observed towards a tecreted lipate 
of the human pathogen hlyrobaeterium tutrerru/osi.c, opening up the 
possibility that lipases of C. albicans may be involved in virulence 
w] Secreted aspartyl proteinases of Candida 
albicans: regulation of transcription and 
promoter sequence analysis 
K. Schrbppel', C. Csank', M. RoUinghoF. 'Iiutitntfiir Kfinisehc 
hfikrobiulogie, Immunolqie und Hygiene, Ciniwsitht Erlar~pi ,  
Germany; ZNational Research Council, ,2lor7trral, Canada 
Component? of conserved nipal transduction pathway? are required 
for starvation (CstWp, Hst7p. Ceklp, Stel?p) or serurn-induzcd (Efg 
lp) hypha formation in the human pathogen Cmdida  albicarts. The 
MAP kinase phosphatase CPPl is an antagonist of hypha formation, 
and a cpp 1 /cpp 1 mutant, derepressed for filamentous growth in vitro 
on solid surfaces, was avirulent in a mouse infection model. Here we 
66 Cl in ica l  M i c r o b i o l o g y  and In fec t ion ,  Vo lume 5 Supp lement  3 
describe how in the hyphae of C. albirans, the rppl /cppl  mutation 
activates transcription of a putative virulence determinailt, the 
secreted aspartyl proteinases S A P 4 4  In an e$gl/efsl mutant, SAP4-6 
gene expression is completely absent. Hence, cekl /cekl reverted the 
morphologic phenotypes of cpp 1 /cpp 1 .  The cpp 1 /cpp 1 rek 1 /cek 1 
double mutant maintains overexpression of SAP4-6. We detected 
differences in putative Stel2p and Teclp transcription factor binding 
sites in the 5-UTRs of the SAP4-6 isogenes. A functional signi- 
ficance for these features was established by ribonuclease protection 
assay-derived measurements of transcriptional activity at the SAP4-6 
isogene loci. A putative C. albicanr TECl  homolog was identified, 
which encodes a TEA/ATTS DNA-binding domain containing 
polypeptide 
Differential expression of secreted aspartyl 
proteinases by RT-PCR and immunoelectron 
microscopy in a model of human oral 
candidosis and in patient samples from the 
oral cavity 
H.C. Korting’, M. Schaller’, W. Schafer’, B. Hube’. 
‘Dermatologische KIinik und Polikiinik, Ludwig-Maximilians- 
Uniuenitht, Munich, ZInstitutfur Allgemeine Botanik, Angewandte 
Molekularbiologie Ill, Utiiuersitit Hanibutg, Hamburg, Germany 
Objectives: To study the involvement of secretory aspartyl 
proteinases (Sap), a possible virulence factor secreted by Candida 
alhirans, in an in vitro model of oral candidosis and in vivo 
Methods: We examined the temporal regulation of the mRNA 
expression of seven known members of the SAP gene family by RT- 
P C R  in (1) an in vitro model of oral candidosis based on recon- 
stituted human epithelium (RHE) and (2) in clinical samples from 
patients with oral candidosis 
Results: SAPl and SAP3 transcripts were first detected 42 h after 
inoculation of RHE, while at the same time slight morphologic 
alterations of the epithelium were documented by light microscopy. 
SAP6 expression occurred 6 h later concomitantly with germ tube 
formation of some infecting Candida cells and severe lesions of the 
epithelial tissue. SAP2 and SAP8 RT-PCR products were first 
detected 60 h after infection, while SAP4 and SAP5 transcripts were 
never discovered. Thus, a temporal progression of SAP expression in 
the order SAPl and SAP3, SAP6, SAP2 and SAP8 was observed at 
the same time as increasing RHE damage occurred. Expression of 
SAPI, SAP?, SAP3 and SAP6 was also detected by RT-PCR in 
samples from patients suffering from oral candidosis 
Conclusions: Our results suggest that the pathogenesis of 
experimental and clinical oral candidosis is associated with differential 
and temporal regulation of SAP gene expression 
10541 Attenuated virulence of different SAP 
(secretory aspartyl proteinase) null mutants in 
an in vitro model of human oral candidosis 
M. Schaller’, H.C. Korting’, W. Schafer’, B. Hube’. ‘Department of 
Dermafolofl/, Ludw~-Maximilians-Uniuersit), ofMunich, Munich, 
‘Institute for General Botany, Applied hfolecular Biology Ill ,  University qf 
Hamburg, Humbug, Germany 
Objectives: To examine the precise role of Saps in the development 
of histologic alterations in a model of human oral candidosis 
Methods: O n  the one hand, we studied the effect of the aspartyl 
proteinase inhibitor pepstatin A on the experimental infection of 
reconstructed human epidermis in vitro. On the other hand, the 
virulence of different SAP null mutants (delta sapl; delta sap2; delta 
sap3; delta sapl,3 and delta sap4-6) in relation to yeast cells of the 
wild-type strain of Candida albirans was tested. The SAP gene 
expression of the wild-type strain and the mutants was investigated 
by RT-PCR 
Results: The histologic lesion caused by the wild-type strain was 
strongly reduced by pepstatin A and to a lower extent with respect 
to infection with the delta sapl,3 mutant. A somewhat smaller but 
equal reduction of the histologic damage was observed for each of 
the single SAP null mutants. The histologic lesion due to the delta 
sap4-6 mutant was increased in comparison to the wild-type strain. 
In comparison with the SAP gene expression pattern of the wild- 
type strain, an earlier onset of SAP8 expression was exclusively 
demonstrated by the delta sapl and the delta sapl,3 mutants 
Discussion: The results suggest that SAPl-3 but not S A P 4 4  
may be important for this type of candidosis, both in vitro and in 
vivo 
Inflammatory host responses 
wl The biological role of lipopolysaccharide (LPS) 
binding protein (LBP) during acute phase, 
sepsis and SIRS 
R.R. Schumann, J. Zweigner, N. Lamping. Instirut fur Mikrobiologie 
G Hyxiene, Ckarite, Humboldt Uniuersitx Berlin, Germany 
Objectives: During sepsis and SIRS, the host organism mounts 
the acute-phase response, including the upregulation of several 
hepatic acute-phase reactants (APRs). LPS binding protein (LBP) is 
an APR that binds LPS and phospholipids. In vitro, LBP in low 
concentrations has been shown to transfer LPS to its cellular receptor 
CD14, enabling cellular responses such as cytokine production. Here 
we investigate the role of constitutive and acute-phase concentrations 
of LBP in vitro and in vivo in order to elucidate host defense 
mechanisms during sepsis and SIRS 
Methods: Recombinant niurine LBP was expressed in a baculo- 
virus system. A murine sepsis model was established, and the LBP-’. 
mouse was employed. The murine macrophage cell line RAW 264.7 
was instrumental for assessing LBP activity in vitro. Additionally, sera 
froni’sepsis and SIRS patients were analyzed for LBP content by 
ELISA. The biological activity of these sera was assessed in different 
assays for their LPS-transfer and TNF-a-inducing capacity employing 
a FACS assay and FITC-labeled LPS, and a monocyte stimulation 
assay involving TNF-a-ELISA 
Results: High concentrations of LBP in vitro suppressed LPS- 
mediated TNF-a and in a murine peritonitis model suppressed 
cytokine production, hepatic failure and lethality. Although more 
resistant against LPS, the LBP”. mouse is more susceptible to a 
bacterial infection. Sera from sepsis and SIRS patients containing 
high concentrations of LBP failed to enhance LPS transfer to mono- 
cytes and blocked LPS-induced TNF-a synthesis 
Conclusions: LBP in vivo may have a dual function regarding 
the mediation of LPS effects towards host cells. While constitutive 
levels enhance LPS effects, acute-phase levels diminish LPS activity 
and thus may protect the host 
